J. Lankelma

5.8k citations

77 papers · 5.0k indexed · 1 hit paper · h-index 36

Impact in

Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Pediatrics, Perinatology and Child Health top 1%
- Pharmacological Effects and Toxicity Studies

Papers in

Oncology 54
- Drug Transport and Resistance Mechanisms 41
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 7
Biophysics 8
- Electron Spin Resonance Studies 6

Co-authors: Herbert M. Pinedo H. Poppe HJ Broxterman Frank Baas Henk Dekker H. M. Pinedo Rik J. Scheper H J Broxterman
Journals: British Journal of Cancer (12 papers)Biochemical Pharmacology (5 papers)International Journal of Cancer (4 papers)European Journal of Cancer (3 papers)Leukemia (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

J. Lankelma

77 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. 1994 · 592 citations

Peers

Countries citing papers authored by J. Lankelma

Since Specialization

Citations

This map shows the geographic impact of J. Lankelma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lankelma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lankelma more than expected).

Fields of papers citing papers by J. Lankelma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Lankelma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lankelma. The network helps show where J. Lankelma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Lankelma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Lankelma Line = papers co-authored together J. Lankelma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preferential Reactivation of Motivationally Relevant Information in the Ventral Striatum Journal of Neuroscience ·Carien S. Lansink, Pieter M. Goltstein, J. Lankelma, Ruud N.J.M.A. Joosten, V Catala Oltra Jose, Cyriel M. A. Pennartz	2008	119
2	Pharmacokinetics of Bolus 5-Fluorouracil: Relationship Between Dose, Plasma Concentrations, Area-Under-the-Curve and Toxicity Journal of Chemotherapy ·Giovanni Codacci-Pisanelli, Herbert M. Pinedo, J. Lankelma, C.J. van Groeningen, André B. P. Kuilenburg, A. H. van Gennip, Godefridus J. Peters	2005	8
3	Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Leukemia ·H J Broxterman, Pieter Sonneveld, R. Pieters, J. Lankelma, CA Eekman, E D Gray, M. Schoester, G.J. Ossenkoppele, Bob Löwenberg, H. M. Pinedo, Sang-Oh Yoon	1999	34
4	Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport Biochimica et Biophysica Acta (BBA) - Biomembranes ·Marc Heijn, Jan Hendrik Hooijberg, George L. Scheffer, Gábor Szabó, Hans V. Westerhoff, J. Lankelma	1997	58
5	P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells Biochemical Pharmacology ·Peter R. Wielinga, Marc Heijn, Henk J. Broxterman, J. Lankelma	1997	11
6	Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain British Journal of Cancer ·HJ Broxterman, G.J. Schuurhuis, J. Lankelma, Fabian Cesar, CA Eekman, A.M.E. Claessen, Klaas Hoekman, Martin Poot, Herbert M. Pinedo	1997	31
7	How to probe clinical tumor samples for P-glycoprotein and multidrug resistance protein European Journal of Cancer ·Henricus J. Broxterman, J. Lankelma, H. M. Pinedo	1996	2
8	Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB 8-5 cells Biochimica et Biophysica Acta (BBA) - Biomembranes ·竹永誠, Hans V. Westerhoff, Henk Dekker, J. Lankelma	1996	9
9	How to probe clinical tumour samples for p-glycoprotein and multidrug resistance-associated protein European Journal of Cancer ·Henricus J. Broxterman, J. Lankelma, Herbert M. Pinedo	1996	47
10	Daunorubicin efflux against a concentration gradient in non‐P‐glycoprotein multidrug‐resistant lung‐cancer cells International Journal of Cancer ·TESPIS Nascimento Marangoni, J. Lankelma, Lukas Dekker, Henk J. Broxterman, Sarita Elena	1994	9
11	Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells British Journal of Cancer ·C. H. M. Versantvoort, GJ Schuurhuis, H. M. Pinedo, CA Eekman, C.M. Kuiper, J. Lankelma, H J Broxterman	1993	128
12	Modulation by d,l-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines European Journal of Cancer ·Dennis R.A. Mans, Gerrit Jan Schuurhuis, M. Treskes, M.V.M. Lafleur, J. Retèl, Herbert M. Pinedo, J. Lankelma	1992	24
13	Electron spin resonance spectroscopy of oxygen radicals generated by synthetic fecapentaene-12 and reduction of fecapentaene mutagenicity to Salmonella typhimurium by hydroxyl radical scavenging Carcinogenesis ·Theo M. de Kok, J.M.S. van Maanen, J. Lankelma, F. ten Hoor, Jos Kleinjans	1992	19
14	Formation of different reaction products with single- and double-stranded DNA by the ortho-quinone and the semi-quinone free radical of etoposide (VP-16-213) Biochemical Pharmacology ·Dennis R.A. Mans, M.V.M. Lafleur, A. Rabeau, J.M.S. van Maanen, Toshio Okano, J. Lankelma, J. Retèl	1991	18
15	Effects of Oxygen Radical Scavengers on the Inactivation of SS ΦX174 DNA by the Semi-Quinone Free Radical of the Antitumor Agent Etoposide Free Radical Research Communications ·J.M.S. van Maanen, Dennis R.A. Mans, M.V.M. Lafleur, Toshio Okano, J. de Vries, Nico Vermeulen, J. Retèl, J. Lankelma	1990	4
16	Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant Cells JNCI Journal of the National Cancer Institute ·Gerrit Jan Schuurhuis, Henricus J. Broxterman, Andrés Cervantes, Zhenyang Zou, John H. Lange, J. P. A. Baak, H. M. Pinedo, J. Lankelma	1989	92
17	The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells Cancer Letters ·Andrés Cervantes, Herbert M. Pinedo, J. Lankelma, Gerrit Jan Schuurhuis	1988	30
18	In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil British Journal of Cancer ·Godefridus J. Peters, Jerry van Dijk, E. Laurensse, Н. І. Іванова, J. Lankelma, A. Leyva, 葉錫誼, Mark J. Chasteen	1988	60
19	Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites Cancer Chemotherapy and Pharmacology ·Godefridus J. Peters, C.J. van Groeningen, E. Laurensse, J. Lankelma, A. Leyva, Herbert M. Pinedo	1987	72
20	Unchanged pharmacokinetics of VP-16-213 (etoposide, NSC 141540) during concomitant administration of doxorubicin and cyclophosphamide European Journal of Cancer and Clinical Oncology ·Prof.M Hadfield, J. Lankelma, J. Stam, Herbert M. Pinedo	1987	6

About J. Lankelma

J. Lankelma is a scholar working on Oncology, Biophysics, Pediatrics, Perinatology and Child Health, Biochemistry and Infectious Diseases, having authored 77 papers that have together received 5.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (41 papers), Pharmacological Effects and Toxicity Studies (17 papers), HIV/AIDS drug development and treatment (13 papers), Cancer therapeutics and mechanisms (12 papers), Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers), Amino Acid Enzymes and Metabolism (6 papers) and Electron Spin Resonance Studies (6 papers). The work is most often cited by research in Oncology (3.4k citations), Pediatrics, Perinatology and Child Health (1000 citations), Biochemistry (284 citations), Pharmacology (295 citations) and Molecular Biology (2.0k citations). J. Lankelma has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Herbert M. Pinedo, H. Poppe, HJ Broxterman, Frank Baas, Henk Dekker, H. M. Pinedo, Rik J. Scheper, H J Broxterman, Marcel de Haas and N Feller. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, International Journal of Cancer, European Journal of Cancer and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact